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126a Sunday, February 26, 2012and YFP-tagged carboxy-terminal peptides of CaV1.3, CaV2.1, NaV1.4, and
NaV1.5 channels. Remarkably, the maximal FRET ratios, computed via 3
3-
FRET and E-FRETmethods, equaled unity, arguingwell for a 1:1 stoichiometry
of apoCaMbinding across CaV andNaV ion-channel families. These results mir-
ror functional findings that a single CaM, pre-associated to the carboxy-termini
of these channels, suffices for robust modulation of channel gating. More
broadly, these experiments underscore the power of FRET 2-hybrid assay to dis-
cern multiple aspects of binding interactions within a live-cell context.
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Ca2þ/calmodulin-dependent inactivation (CDI) of CaV channels plays a crucial
role in the homeostasis of intracellular Ca2þ, and serves as an ideal prototype
for investigating Ca2þ feedback regulation within biological systems. The pre-
vailing view of CDI mechanism is that Ca2þ-free calmodulin (apoCaM) preas-
sociates with the IQ domain of the proximal carboxy terminus of channels, and
this ‘resident’ calmodulin (CaM) acts as Ca2þ sensor to somehow trigger CDI
upon Ca2þ binding. The downstream CaM/channel configurations leading to
CDI are complex and under investigation at present. Contrasting with this com-
plexity, CaV1.3 and CaV1.4 feature a long-carboxy-tail splice variant that min-
imizes CDI by a beautifully simple mechanism. We recently combined
electrophysiology and a genetically encoded fluorescent sensor to record CDI
and CaM concentration simultaneously (Nature463:968), thereby demonstrat-
ing that the distal-carboxy-tail (DCT) harbors an ICDI module that competes
with apoCaM for binding to the IQ domain. By kicking off apoCaM, ICDI di-
minishes CDI in an eminently straightforward manner; thus, the IQ/ICDI com-
plex now looms as a simplified prototype for novel channel modulators, and as
an easy entrez into complex CaM/channel configurations underlying CDI.
Here, we perform alanine-scanning mutagenesis of the entire IQ domain and
ICDI domain. Hotspot mutations which reduce IQ/ICDI binding affinity also
commensurately diminish ICDI function (i.e., permit restoration of CDI). Fur-
thermore, the ensemble of effects can be well fit with a Michaelis-Menten equa-
tion incorporating the presence of a competitive inhibitor. Thus, the collection
of hotspots can be used to identify the minimal functional segments of IQ/ICDI
interaction to facilitate structure building, and to provide clues for designing
small peptides and/or molecules that regulate CDI of specific CaV channels.
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Background. The LTCC distal C-terminus (DCT) is proteolytically cleaved,
and re-associates with the LTCC complex to regulate calcium channel function.
DCT reduces LTCC barium current (IBa,L) in reconstituted channel complexes
and mediates the fight or flight response in DCT knockout mice; yet the contri-
bution of DCT to ICa,L in native systems is unexplored. This study examines
the beat-to beat contribution of DCT to LTCC calcium homeostasis in native
cardiomyocytes.
Methods. We measured LTCC current with DCT co-expressed in cardiomyo-
cytes. We also heterologously co-expressed DCT and CaV1.2 constructs
with a stop corresponding to the predicted proteolytic cleavage site,
Cav1.2D1801, and a shorter deletion corresponding to well-studied construct,
Cav1.2D1733 along with CaVb2 subunits.
Results. DCT was found to inhibit IBa,L, but not ICa,L in cardiomyocytes.
DCT blocked IBa,L carried by both Cav1.2D1801 and Cav1.2D1733 in HEK
cells. However, DCT inhibited ICa,L carried by Cav1.2D1801 but not
Cav1.2D1733 channels. As CaM and DCT have adjoining interaction sites
on CaV1.2, we tested if exogenous CaM (CaMex) interferes with DCT current
inhibition in cardiomyocytes and HEK systems. CaMex relieved DCT block in
both systems and both channel variants. Addition of CaM1234 did not relieve
DCT current inhibition or have an additive effect. DCT did not alter voltage
dependence, or activation kinetics. The selective block of IBa,L suggested
that DCT activity may be relieved under conditions of elevated Ca.
Conclusions. DCT blockade of LTCC is apparent only when Ca is not the
charge carrier. Therefore, our data motivates the new hypothesis that DCT is
a native reverse use-dependent inhibitor of LTCC current.
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UMDNJ-NJMS, Newark, NJ, USA.Previoulsy (Biophys. Meetings 2010 and 2011), we showed that inactivation of
L-type Ca2þ channels containing the g1 subunit changes during cell cycle. The
half-inactivation voltage is very negative (in the 70 - 50 mV range) in cells
at the G1 phase, but also after serum starvation, or after the ER shock.
Here we report that the novel regulatory pathway is membrane-delimited be-
cause it depends on cholesterol and sphingolipids. Alterations of the membrane
lipid fluidity (e.g., addition of Triton X-100) affected inactivation regardless of
the g1 subunit. However, variousmanipulations withmembrane cholesterol, ce-
ramide, and/or shpingosine were efficient only when the g1 subunit was present.
Although tested positively in our experimental conditions, phosphoinositides, C-
8-ceramide-1-phosphate, sphingosine-1-phosphate, and glycosphingolipid
GM1 did not act specifically on inactivation with the g1 subunit.
When cholesterol was depleted from the membrane, or upon application of
sphingosine, ceramide-C2, or ceramide-C8, inactivation shifted to the 70 -
50 mV range. Isomers epi-cholesterol and dihydro-ceramide-C2 did not
act. Because ceramide and sphingosine strongly activate phosphatases PP1
and PP2A, phosphatase inhibitors calyculin A, or tautomycetin, were applied
in order to prevent a rapid current run-down. Thus, a role of phosphoryla-
tion-dependent pathways can be excluded as well.
We compared the membrane cholesterol content in cells at different cell-cycle
stages, but did not find any significant difference. However, the membrane con-
tents of sphingosine and ceramide are well known to change during cell cycle.
Therefore, we propose that the enhancement of inactivation of L-type channels
by the g1 subunit is dependent on sphingosine and ceramide. Possibly, the
sphingolipids interact directly with the subunit. The large scale of changes of
inactivation properties due to these interactions allows efficient spatiotemporal
tuning of functional availability of L-type Ca2þ channels.
Supported by R01MH079406.
635-Pos Board B421
Neutralizing the Charges in a Voltage Sensor Repairs Gating Perturba-
tions in the Pore of CaV1.2
Stanislav Beyl, Katrin Depil, Annette Hohaus, Anna Stary-Weinzinger,
Eugen Timin, Steffen Hering.
Pharmacology and Toxicology, Vienna, Austria.
Voltage sensors initiate the closed - open transitions in the ion conducting pore.
Here we consecutively neutralized the charges of the four S4 segments (IS4-
IVS4) of CaV1.2. The channel construct lacking charges in IIS4 (IIS4N) con-
ducted barium currents. Surprisingly, charge neutralization accelerated channel
closure and diminished shifts of the activation curves also in S6 mutants (IS6:
G432W/IIS4N, IIS6: A780T/IIS4N, IIIS6: G1193T/IIS4N, IVS6: A1503G/
IIS4N). Such a rescue of S6-mediated gating perturbations is exemplified for
the IVS6 mutation A1503G. A1503G induced a22.651.2 mV shift of the ac-
tivation curve to the left that was diminished by charge neutralization in IIS4.
Gating disturbances induced by pore mutations upstream and downstream of
G432, G1193 and A1503 were unaffected.
Thermodynamic analysis reveals that seg-
ment IIS4 interacts (energetically cou-
pled) with a ring of small homologous
amino acids G432, A780, G1193 and
A1503 (G/A/G/A ring, Depil et al. 2011)
in all four pore forming S6 segments.
The research was funded by the Austrian
Science Fund (FWF): grant P22600-B12
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L-type calcium current (Cav1.2) plays a key role in modulation of multiple car-
diovascular functions. Therefore, Cav1.2 calcium current assay is useful in
screening discovery compounds for potential cardiovascular (CV) liabilities.
L-type calcium current itself is highly sensitive to temperature. However, it
is not known if drug effects on this current are influenced by temperature. Using
whole-cell voltage clamp techniques, we compared the effects of room (22-24
C) and physiological (37 C) temperatures on the current in the absence and
presence of a calcium current activator (TTYC) in CHO cells stably expressing
L-type calcium channels. Under our experiment conditions (2 mM [Ca2þ]o),
calcium current amplitude in CHO cells was increased approximately 4-fold
with warming from 24 to 37 C; the half maximal activation voltage (V1/2)
was shifted from 6.4 mV (24 C) to 17 mV (37 C). The calcium channel
activator TTYC (0.3 uM, Su et al. 2010) increased peak current by 925 10 %
